Sugar Maple Asset Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$556K Buy
6,660
+660
+11% +$54.3K 0.32% 57
2026
Q2
$399K Buy
6,000
+3,000
+100% +$254K 0.26% 59
2026
Q1
$298K Hold
3,000
– – 0.18% 71
2025
Q4
$365K Hold
3,000
– – 0.25% 61
2025
Q3
$337K Sell
3,000
-1,000
-25% -$117K 0.24% 63
2025
Q2
$536K Sell
4,000
-7,000
-64% -$769K 0.42% 41
2025
Q1
$740K Buy
+11,000
New +$757K 0.58% 33

Other funds holding TMDX

Sugar Maple Asset Management's TMDX Position: Q3 2026 in Review

Sugar Maple Asset Management increased its Transmedics (TMDX) stake by 11% in Q3 2026, buying an estimated $54.3K and bringing the position to 6,660 shares worth $556K. The position accounts for 0.32% of the portfolio, ranked #57.

Sugar Maple Asset Management first reported a position in TMDX in Q1 2025 and has held it in 7 quarters since. The position peaked at $740K in Q1 2025. 384 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • Sugar Maple Asset Management held 6,660 shares of Transmedics worth $556K as of Q3 2026.
  • Sugar Maple Asset Management bought 660 Transmedics shares in Q3 2026, an estimated $54.3K.
  • Transmedics made up 0.32% of Sugar Maple Asset Management's portfolio in Q3 2026, its #57 holding.
  • Sugar Maple Asset Management first reported a position in Transmedics in Q1 2025 and has held it in 7 quarters since.
  • Sugar Maple Asset Management's Transmedics position peaked at $740K in Q1 2025.
  • 384 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Sugar Maple Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.